eMolecules logo
Verified via Expert Interviews

eMolecules: Revenue, Valuation & Competitors

eMolecules company overview

Ownership
PE-backed
Employees
51
Investors
Avista Healthcare Partners
Revenue / FTE
$1•••k

About

Offers chemical search and fulfilment software and solutions for pharmaceutical and biotechnology researchers and organizations to acquire, reformat, and manage chemical and biological compounds.
USA
Global
Verified via Expert Interviews

Expert Vetted Data

Public disclosures rarely capture a company's internal dynamics or the true state of its technology. Gain first-hand insight by speaking with former eMolecules executives.

Ownership & Key Financials

Revenue

$1••m '••
1

Investors

Avista Healthcare Partners
'21
1

Revenue / FTE

$1•••k '••
1

Ownership

PE-backed
1

FTEs

1
+5% CAGR
39
2020
50
2021
53
2022
51
2023
51
2024

Legal Disclaimer

The company profiles displayed here are abridged, indicative previews of the full, proprietary data available within the Dialectica Origin Platform, derived from confidential sources and expert-vetted research. This content is the exclusive Intellectual Property (IP) of Dialectica. Your access does not grant any rights to the data. Systematic copying, scraping, crawling, indexing, or extraction, whether by manual means, automated software, bots, or Large Language Models (LLMs), is strictly prohibited and violates our Terms of Use.

This information is provided 'as is' for promotional purposes only; Dialectica disclaims all liability for its accuracy, completeness, or any reliance placed upon it.